AHA and Google Life Sciences Partner on Heart Disease Research | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

AHA and Google Life Sciences Partner on Heart Disease Research

November 10, 2015
by Heather Landi
| Reprints

Technology will play a critical role in a new research collaboration between the American Heart Association (AHA) and Google Life Sciences to bring “new, unconventional thinking” to the study and prevention of coronary heart disease.

Each organization will commit $25 million for a combined $50 million over five years to support novel strategies to understand, prevent and reverse heart disease and its consequences, such as heart failure and sudden cardiac death.

Through technology, the collaboration will provide the scientific community with channels to technical capabilities and insights offered by Google Life Sciences. With the unique opportunity to access such resources, the collaboration will expand research pathways and empower researchers to conceptualize and test new approaches, the companies said in a press release.

AHA will contribute its vast scientific and medical resources, resulting in the application of a unique blend of technical and scientific knowledge to the search for new cardiovascular solutions.

“This is a fundamentally different kind of model for funding innovation,” Andy Conrad, CEO of Google Life Sciences, said. “The team leader will be able to bring together clinicians, engineers, designers, basic researchers and other experts to think in new ways about the causes of coronary heart disease. We’re already imagining the possibilities when a team like that has access to the full resources of both Google Life Sciences and the AHA -- and we can’t wait to see what they discover.”

Cardiovascular diseases are the number one cause of death globally, accounting annually for approximately 17 million deaths, or about one of every three deaths.  According to the companies, traditional research funding models, which are often incremental and piecemeal, make it difficult to study a multifaceted subject that plays out over many years. As such, AHA and GLS have committed to a different approach with a $50 million investment in one research team, which will be tasked with developing an understanding of cardiovascular disease.

 “With its devastating human impact on countless generations of families, cardiovascular disease, and in particular coronary heart disease remains the greatest and deadliest global health challenge we face today,” American Heart Association CEO Nancy Brown said. “By working together, AHA and Google Life Sciences will be able to serve as the catalyst for change and transformation in reducing the impact of coronary heart disease on people’s lives and alleviating this global burden.”

 

 

Topics

News

Dignity Health, CHI Merging to Form New Catholic Health System

Catholic Health Initiatives (CHI), based in Englewood, Colorado, and San Francisco-based Dignity Health officially announced they are merging and have signed a definitive agreement to combine ministries and create a new, nonprofit Catholic health system.

HHS Announces Winning Solutions in Opioid Code-a-Thon

The U.S. Department of Health and Human Services (HHS) hosted this week a first-of-its-kind two-day Code-a-Thon to use data and technology to develop new solutions to address the opioid epidemic.

In GAO Report, More Concern over VA VistA Modernization Project

A recent Government Accountability Office (GAO) report is calling into question the more than $1 billion that has been spent to modernize the Department of Veterans Affairs' (VA) health IT system.

Lawmakers Introduce Legislation Aimed at Improving Medicare ACO Program

U.S. Representatives Peter Welch (D-VT) and Rep. Diane Black (R-TN) have introduced H.R. 4580, the ACO Improvement Act of 2017 that makes changes to the Medicare accountable care organization (ACO) program.

Humana Develops Medication Management Tool

A new tool developed by Humana enables the company’s members to keep a list of their medications in one place.

Four Hospitals Piloting OurNotes Initiative in 2018

Beginning in January, four academic hospitals—Beth Israel Deaconess Medical Center in Boston, University of Washington in Seattle, Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire and University of Colorado in Boulder—will begin piloting a new digital tool called OurNotes that enables patients to contribute to their clinical notes.